Total Payments
$11,126
2024 Payments
$2,767
Companies
38
Transactions
619
Medicare Patients
1,251
Medicare Billing
$81,127
Payment Breakdown by Category
Food & Beverage$11,060 (99.4%)
Education$66.67 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,060 | 615 | 99.4% |
| Education | $66.67 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,343 | 143 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,651 | 92 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,254 | 84 | $0 (2024) |
| Janssen Biotech, Inc. | $869.86 | 50 | $0 (2024) |
| Gilead Sciences, Inc. | $549.66 | 25 | $0 (2024) |
| Ardelyx, Inc. | $479.74 | 25 | $0 (2024) |
| GENZYME CORPORATION | $423.58 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $399.73 | 13 | $0 (2024) |
| Celgene Corporation | $384.64 | 24 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $295.97 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,767 | 141 | Takeda Pharmaceuticals U.S.A., Inc. ($357.93) |
| 2023 | $2,898 | 161 | Takeda Pharmaceuticals U.S.A., Inc. ($483.56) |
| 2022 | $2,984 | 166 | ABBVIE INC. ($757.63) |
| 2021 | $2,478 | 151 | AbbVie Inc. ($770.92) |
All Payment Transactions
619 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.56 | General |
| 12/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.34 | General |
| 11/08/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $31.75 | General |
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Immunology | ||||||
| 10/21/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.79 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $1.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.83 | General |
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 319 | 383 | $112,478 | $23,305 |
| 2022 | 6 | 277 | 336 | $90,829 | $18,391 |
| 2021 | 5 | 328 | 414 | $113,065 | $23,946 |
| 2020 | 6 | 327 | 389 | $48,841 | $15,485 |
Total Patients
1,251
Total Services
1,522
Medicare Billing
$81,127
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 194 | 254 | $60,198 | $13,036 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 71 | $24,708 | $5,354 | 21.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $20,054 | $3,680 | 18.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $7,518 | $1,235 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 162 | 215 | $50,955 | $10,652 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 37 | $12,876 | $2,823 | 21.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $10,840 | $1,886 | 17.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $7,160 | $1,366 | 19.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 32 | 33 | $4,686 | $978.69 | 20.9% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2022 | 11 | 11 | $4,312 | $686.51 | 15.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 202 | 285 | $67,545 | $14,775 | 21.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 48 | 51 | $17,748 | $3,891 | 21.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 25 | 25 | $13,550 | $2,583 | 19.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 31 | 31 | $11,098 | $2,048 | 18.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 22 | $3,124 | $648.82 | 20.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 145 | 182 | $25,638 | $7,565 | 29.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 50 | 56 | $9,236 | $2,407 | 26.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 60 | 72 | $3,402 | $1,905 | 56.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 33 | 40 | $2,950 | $1,816 | 61.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 13 | 13 | $5,211 | $1,138 | 21.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 26 | 26 | $2,404 | $652.73 | 27.2% |
About Jonathan Mccrary, CRNP
Jonathan Mccrary, CRNP is a Acute Care healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/03/2018. The National Provider Identifier (NPI) number assigned to this provider is 1962972968.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan Mccrary, CRNP has received a total of $11,126 in payments from pharmaceutical and medical device companies, with $2,767 received in 2024. These payments were reported across 619 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($11,060).
As a Medicare-enrolled provider, Mccrary has provided services to 1,251 Medicare beneficiaries, totaling 1,522 services with total Medicare billing of $81,127. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location Birmingham, AL
- Active Since 12/03/2018
- Last Updated 12/03/2018
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1962972968
Products in Payments
- ENTYVIO (Biological) $1,342
- DUPIXENT (Biological) $823.31
- STELARA (Biological) $766.41
- XIFAXAN (Drug) $675.24
- HUMIRA (Biological) $657.06
- LINZESS (Drug) $581.23
- TRULANCE (Drug) $578.73
- ZEPOSIA (Drug) $508.54
- IBSRELA (Drug) $479.74
- RINVOQ (Biological) $337.10
- ZENPEP (Drug) $314.62
- Linzess (Drug) $295.97
- SKYRIZI (Biological) $264.51
- GIMOTI (Drug) $250.10
- XELJANZ (Drug) $249.65
- MAVYRET (Drug) $211.14
- SUTAB (Drug) $188.77
- SUCRAID (Drug) $182.50
- CREON (Drug) $146.61
- GATTEX (Drug) $128.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Birmingham
Shelby Nesbitt
Acute Care — Payments: $11,341
Acute Care $11,341
Cameron Stephenson, Np, NP
Acute Care — Payments: $10,840
Acute Care $10,840
Melissa French, Crnp, CRNP
Acute Care — Payments: $10,050
Acute Care $10,050
Mrs. Jaime Cannon, Crnp, CRNP
Acute Care — Payments: $9,547
Acute Care $9,547
Kaci Weaver
Acute Care — Payments: $9,186
Acute Care $9,186
Mrs. Michelle Price, Crnp, CRNP
Acute Care — Payments: $8,972
Acute Care $8,972